drugset / Trial / NCT04252521

Intravenous Metoclopramide Versus Dexketoprofen Trometamol Versus Metoclopramide+ Dexketoprofen Trometamol in Migraine

NCT04252521

Completed 150 enrolled Adiyaman University Research Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Acute headache is one of the most common reasons for presentation to the emergency department (ED), accounting for 2-3% of all emergency visits. Migraine is a disorder of the central nervous system characterized by a moderate or severe headache, which is generally associated with nausea and/or sensitivity to light and sound, interfering with daily activities.

Timeline

Start
2019-07-03
Primary completion
2020-01-03
Completion
2020-01-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexketoprofen Small molecule 50 mg Intravenous
Subject Metoclopramide Small molecule 10 mg Intravenous

Indications